Use access key #2 to skip to page content.
$51.09 -0.20 (-0.39%)
7/3/2008 1:00 PM

Gilead Sciences, Inc. (GILD)

CAPS Rating:
*****

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

View Ticker Page (GILD)

Results 1 - 10 of 152 :   12345Next »

Recs

9

Avatar NetscribeBiotech (73.62) Submitted: 2/27/07 8:13 AM : Outperform Start Price: $36.70 GILD Score: 51.42

Gilead Sciences, Inc. (Gilead) is a multinational biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The company draws its revenues from nine ap...

Report this Post Replies: 1 | Reply | Permalink

Recs

5

Avatar Hogwired1 (95.44) Submitted: 8/18/06 6:01 PM : Outperform Start Price: $31.78 GILD Score: 63.58

GILD is a solidly run biotech with an outstanding balance sheet and industry leading aids franchise. This company has substantially outperformed the market and should continue to outperform.

Report this Post Replies: 0 | Reply | Permalink

Recs

4

Avatar syljtffreedom (84.00) Submitted: 2/05/07 8:21 PM : Outperform Start Price: $34.99 GILD Score: 58.86

Has patents to two very important drugs eg Tamiflu and HIV antiretroviral drug which is likely to have strong demand in the future. Personnels such as Bill Gates have been pledging its support to distribute and provide easier access to these drugs in...

Report this Post Replies: 0 | Reply | Permalink

Recs

3

Avatar leosshoes (39.23) Submitted: 1/01/08 10:47 AM : Outperform Start Price: $45.96 GILD Score: 24.96

Gilead is competing with the big boys and holding it's own. The share price has held up just fine over the otherwise not so pretty market picture of the past couple of months. income and profits look to continue rising. what's not to like?

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar NYCKrebs (96.49) Submitted: 1/09/07 12:52 AM : Outperform Start Price: $32.52 GILD Score: 67.66

Tomorrow the JP Morgan Biotech conference will explain the recent purchase that scared the price of this stock down. They diversified their targeted disease base without explination. Tomorrow investors will get there security blanket back and will ...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar jfosu (99.40) Submitted: 3/24/08 1:19 PM : Outperform Start Price: $34.81 GILD Score: 55.84

From a small cap in the mid 90s to a large pharma player today this company has always shown it knows how to stay ahead of the game. Just look at its HIV franchise - Gilead currently produces the ONLY once a day HIV pill on the market. Already approv...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar gmathew85 (81.91) Submitted: 4/25/07 11:13 PM : Outperform Start Price: $41.97 GILD Score: 37.25

You won't be laughing when you contract bird flu from some bad KFC. GILD execs will be laughing though, all the way to the bank.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar NoVaAmPro (74.01) Submitted: 12/01/06 1:36 PM : Outperform Start Price: $32.16 GILD Score: 68.41

I bought this one to tap into the anti-viral industry, and Gilead looked like one of the bigger players. Done well by it, so far. Here's an amusing observation: compare the stock performance during the 90s, when it was run by Rumsfeld, to its perfo...

Report this Post Replies: 1 | Reply | Permalink

Recs

1

Avatar eslough (94.31) Submitted: 9/26/07 1:20 PM : Outperform Start Price: $41.00 GILD Score: 41.71

Gilead Sciences is an Israeli biopharmaceutical company engaged in the discovery, development, and commercialization of therapeutics for the treatment of life-threatening infectious diseases. It has an extremely rich pipeline and the stock sells at ...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar rncox (64.60) Submitted: 5/23/07 4:05 PM : Outperform Start Price: $31.56 GILD Score: 72.45

Gilead is one of the pure small molecule pharma plays and that is the future. I also like the fact that they are going after the scourges of infectious diseases: HIV, HepB, HepC, and mass viral and fungal. It's those little guys they treat, that are...

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners